Torthaí cuardaigh - David Back

Beachtaigh na torthaí
  1. 1
    The challenge of HIV treatment in an era of polypharmacy

    The challenge of HIV treatment in an era of polypharmacy de réir David Back, Catia Marzolini

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned

    Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned de réir David Back, David M. Burger

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals

    New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals de réir Kay Seden, David Back, Saye Khoo

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Maraviroc: Pharmacokinetics and drug Interactions

    Maraviroc: Pharmacokinetics and drug Interactions de réir Sylvie Abel, David Back, Manoli Vourvahis

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes

    Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes de réir Victoria A. Eagling, John Tjia, David Back

    Foilsithe / Cruthaithe 1998
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors

    Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors de réir Louise Profit, Victoria A. Eagling, David Back

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir

    Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir de réir Victoria A. Eagling, David Back, Michael Barry

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Darunavir: Pharmacokinetics and Drug Interactions

    Darunavir: Pharmacokinetics and Drug Interactions de réir David Back, Vanitha Sekar, Richard M. W. Hoetelmans

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid)

    Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid) de réir Laura Else, Stephen Taylor, David Back, Saye Khoo

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells

    Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells de réir Philip Martin, R Riley, David Back, Andrew Owen

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications

    Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications de réir Catia Marzolini, Sara Gibbons, Saye Khoo, David Back

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Differences in the cytochrome <i>P</i>-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes

    Differences in the cytochrome <i>P</i>-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes de réir S. Ball, Lesley M. Forrester, C. Roland Wolf, David Back

    Foilsithe / Cruthaithe 1990
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Stopping antiretroviral therapy

    Stopping antiretroviral therapy de réir Stephen Taylor, Marta Boffito, Saye Khoo, Erasmus Smit, David Back

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

    Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine de réir Daryl Hodge, David Back, Sara Gibbons, Saye Khoo, Catia Marzolini

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

    Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro de réir Patrick G. Hoggard, Stephen Kewn, Michael Barry, Saye Khoo, David Back

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients

    Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients de réir Concepta Merry, Michael Barry, Fiona Mulcahy, Kathryn L. Halifax, David Back

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

    Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine de réir Beth Williamson, Kelly E. Dooley, Yuan Zhang, David Back, Andrew Owen

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz

    The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz de réir S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users

    Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users de réir S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

    Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect de réir Felix Stader, Saye Khoo, Marcel Stoeckle, David Back, Hans H. Hirsch, Manuel Battegay, Catia Marzolini

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: